| DRUG WATCH |
|
| Year : 2017 | Volume
: 49
| Issue : 5 | Page : 396-398 |
Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus
Sarayu Pai1, Renuka Munshi1, Chitra Nayak2
1 Department of Clinical Pharmacology, TN Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra, India
2 Department of Dermatology, TN Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra, India
Correspondence Address:
Dr. Renuka Munshi
Department of Clinical Pharmacology, TN Medical College and BYL Nair Charitable Hospital, Mumbai Central, Mumbai - 400 008, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_764_16
Dapsone has been part of the World Health Organization multidrug therapy for the treatment of leprosy. While it has been efficacious in the management of leprosy, there are many patients who develop adverse drug reactions to the drug including life-threatening reactions such as dapsone hypersensitivity syndrome (DHS). We report a case of a patient who was prescribed dapsone as part of multidrug therapy for leprosy following which she developed DHS. Her condition worsened after tapering the oral steroids given to manage the DHS, and she was detected to have hypothyroidism. She developed diabetes mellitus and succumbed to septic shock.
[FULL TEXT] [PDF]*
|
